MAPT and early-onset autosomal dominant Alzheimer disease: It is well known that reduced clearance of amyloid-β plays a role in the pathophysiology of Alzheimer’s disease (AD) (Kress et al., 2014), and decreased clearance of phosphorylated tau is associated with chronic traumatic encephalopathy (Plog et al., 2015).